TransMedics Group operates an organ transplant ecosystem under which it offers patented technology to preserve and mobilize organs, services that support transplant centers and medical teams, and a ...

Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” fourth-quarter 2024 ...

New York, New York-- (Newsfile Corp. - March 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics") on behalf of those who ...

If you purchased or acquired securities in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...

The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...

TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...

Outside of the U.S., where OrganOx has a larger footprint, livers account for about 1% of TransMedics Group's sales. If ...

NasdaqGM:TMDX Earnings and Revenue History March 7th 2025 A Closer Look At TransMedics Group's Earnings. One key financial ratio used to measure how well a company converts its pr ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, ...

Equities research analysts at William Blair raised their Q3 2025 earnings estimates for shares of TransMedics Group in a ...

TransMedics' stock has rebounded modestly in recent months on the back of a strong fourth quarter performance. Continued market growth and TransMedics' return to gaining market share should help ...